Kaplan, Kevin A.
Elsea, Sarah H.
Potocki, Lorraine
Article History
First Online: 3 June 2020
Compliance with Ethical Standards
:
: No funding sources were used for the preparation of this article.
: Sarah H. Elsea receives research funding from the Smith-Magenis Syndrome Research Foundation, PRISMS, Inc., Fondation Jerome Lejeune, Rhythm Therapeutics, and Vanda Pharmaceuticals. Kevin A. Kaplan and Lorraine Potocki have no conflicts of interest that are directly relevant to the content of this article.